ATE543805T1 - Verfahren zur herstellung von oxazolidinonderivaten - Google Patents

Verfahren zur herstellung von oxazolidinonderivaten

Info

Publication number
ATE543805T1
ATE543805T1 AT08170827T AT08170827T ATE543805T1 AT E543805 T1 ATE543805 T1 AT E543805T1 AT 08170827 T AT08170827 T AT 08170827T AT 08170827 T AT08170827 T AT 08170827T AT E543805 T1 ATE543805 T1 AT E543805T1
Authority
AT
Austria
Prior art keywords
oxazolidinone derivatives
producing
producing oxazolidinone
derivatives
linezolid
Prior art date
Application number
AT08170827T
Other languages
English (en)
Inventor
Lino Colombo
Pietro Allegrini
Marco Brusasca
Arienzo Giuseppe D
Gabriele Razzetti
Original Assignee
Dipharma Francis Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dipharma Francis Srl filed Critical Dipharma Francis Srl
Application granted granted Critical
Publication of ATE543805T1 publication Critical patent/ATE543805T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT08170827T 2007-12-18 2008-12-05 Verfahren zur herstellung von oxazolidinonderivaten ATE543805T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002359A ITMI20072359A1 (it) 2007-12-18 2007-12-18 Procedimento per la preparazione di derivati ossazolidinonici

Publications (1)

Publication Number Publication Date
ATE543805T1 true ATE543805T1 (de) 2012-02-15

Family

ID=40315597

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08170827T ATE543805T1 (de) 2007-12-18 2008-12-05 Verfahren zur herstellung von oxazolidinonderivaten

Country Status (4)

Country Link
US (1) US20090156806A1 (de)
EP (1) EP2072505B1 (de)
AT (1) ATE543805T1 (de)
IT (1) ITMI20072359A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2033960A3 (de) 2007-09-04 2009-04-29 Dipharma Francis S.r.l. Kristalline Linezolidhydratform und Linezolidsalze
WO2014174522A1 (en) * 2013-04-25 2014-10-30 Symed Labs Limited Improved processes for the preparation of linezolid using novel intermediates
CN103804315B (zh) * 2014-02-20 2015-12-09 四川大学 一种5-氨甲基噁唑烷酮类化合物的制备方法
CN105111160B (zh) * 2015-09-11 2017-04-12 浙江新东港药业股份有限公司 一种利奈唑胺的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5839870A (en) * 1996-03-13 1998-11-24 Novus Corporation Transfer system for use with a horizontal furnace
HUP0004388A3 (en) * 1997-11-07 2001-10-29 Upjohn Co Process for the preparation of oxazolidinones, intermediates and preparation thereof
US6444813B2 (en) * 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
US6833453B2 (en) * 2000-10-17 2004-12-21 Pharmacia & Upjohn Company Methods of producing oxazolidinone compounds
WO2002085849A2 (en) * 2001-04-20 2002-10-31 Pharmacia & Upjohn Company Process to prepare oxazolidinones
MX2007000084A (es) * 2004-06-29 2007-06-14 Teva Pharma Formas solidas de linezolid y procesos para la preparacion delas mismas.
JP2007504173A (ja) * 2004-06-29 2007-03-01 テバ ファーマシューティカル インダストリーズ リミティド リネゾリドのiv型結晶

Also Published As

Publication number Publication date
ITMI20072359A1 (it) 2009-06-19
US20090156806A1 (en) 2009-06-18
EP2072505A2 (de) 2009-06-24
EP2072505A3 (de) 2009-08-12
EP2072505B1 (de) 2012-02-01

Similar Documents

Publication Publication Date Title
WO2009063505A3 (en) Process for preparation of (s) (n-[[3-[3-fluoro-4-(4-morpholinyl) hen l -2-oxo-5-oxazolidin l methyl]acetamide
MY150980A (en) Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
DE602006020682D1 (de) Synthetische Perlmutter, Verfahren und Vorrichtung zu ihrer Herstellung
DE50313496D1 (de) VERFAHREN ZUR HERSTELLUNG VON 5-CHLOR- i N /i -({5S)-2-OXO-3- 4-(3-OXO-4-MORPHOLINYL)-PHENYL -1,3-OXAZOLIDIN-5-YL&r cub;-METHYL)-2-THIOPHENCARBOXAMID
ATE539993T1 (de) Verfahren und vorrichtung zur herstellung von röhrenförmigen wickelkernen
ATE543805T1 (de) Verfahren zur herstellung von oxazolidinonderivaten
ATE536165T1 (de) Dentalabdruckmaterial mit rheologischen modifikatoren und verfahren zu seiner herstellung
IL194719A0 (en) Process for the preparation of cinacalcet base
DE502005001841D1 (de) Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten
DE602004018386D1 (de) Verfahren zur herstellung von 4-(2-dipropylaminoethyl)-1,3-dihydro-2h-indol-2-on-hydrochlorid
EA201391647A1 (ru) Способ получения ривароксабана и промежуточные соединения, получаемые в указанном способе
PE20141943A1 (es) Antagonistas de trpv4
DE602005003791D1 (de) Verfahren zur herstellung von 1-(2s,3s)-2-benzhydril-n-(5-tert.-butyl-2-methoxybenzyl)chinuklidin-3-amin
PE20091431A1 (es) Compuestos derivados de azetidinas, su preparacion y su aplicacion en terapeutica
DE502004004289D1 (de) Isolierteil, ringkern, ringkerndrossel und verfahren zur herstellung der ringkerndrossel
DE502007001402D1 (de) Aminoacyl-prodrug derivate und arzneimittel zur behandlung von thromboembolischen erkrankungen
DE602006019454D1 (de) Hochreines hafnium, target und hochreines hafnium umfassender dünner film und verfahren zur herstellung von hochreinem hafnium
ATE552250T1 (de) Verfahren zur herstellung von duloxetin und verwandten verbindungen
CY1113722T1 (el) Μεθοδος για την παρασκευη toy cinacalcet
DE502005003879D1 (de) Verfahren zur kontinuierlichen herstellung von amino-gruppen tragenden silicium-verbindungen
ATE372336T1 (de) Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
DE602006005513D1 (de) Verfahren zur herstellung von delmopinol und derivaten davon
DE502005000184D1 (de) Verfahren zur Herstellung von linearen Si-H-Gruppen aufweisenden Organopolysiloxanen
DE602005012171D1 (de) Methode zur Herstellung einer Riemenscheibe, Methode zum Spritzgiessen von Einsatzkomponenten und Einsatzkomponente
ATE527228T1 (de) Verfahren zur herstellung von beta-santalol und derivaten davon